Interleukin-1α inhibitor bermekimab in patients with atopic dermatitis: randomized and nonrandomized studies.
- DOI
- 10.1007/s00403-024-03319-z
- Published
- 2024 Aug 30
- Container
- Archives of dermatological research
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s00403-024-03319-z,
title = {Interleukin-1α inhibitor bermekimab in patients with atopic dermatitis: randomized and nonrandomized studies.},
author = {Simpson EL and Guttman-Yassky E and Pawlikowski J and Ghorayeb EG and Ota T and Lebwohl MG},
year = {2024},
journal = {Archives of dermatological research},
doi = {10.1007/s00403-024-03319-z},
url = {https://doi.org/10.1007/s00403-024-03319-z}
}RIS
TY - JOUR TI - Interleukin-1α inhibitor bermekimab in patients with atopic dermatitis: randomized and nonrandomized studies. AU - Simpson EL AU - Guttman-Yassky E AU - Pawlikowski J AU - Ghorayeb EG AU - Ota T AU - Lebwohl MG PY - 2024 JO - Archives of dermatological research DO - 10.1007/s00403-024-03319-z UR - https://doi.org/10.1007/s00403-024-03319-z ER -
APA
EL, S., E, G., J, P., EG, G., T, O., & MG, L. (2024). Interleukin-1α inhibitor bermekimab in patients with atopic dermatitis: randomized and nonrandomized studies.. Archives of dermatological research. https://doi.org/10.1007/s00403-024-03319-z
Source records
- pubmed · retrieved 2026-09-25T08:08:12.972Z